Inactivated Polio Vaccines Broadly Available for the World’s Children in the Drive Toward Polio Eradication

March 3, 2014

LYON, France, March 3, 2014 /PRNewswire/ –

– Sanofi Pasteur works with global partners to make available unparalleled

quantities of affordable Inactivated Polio Vaccine (IPV) -

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY),
announced today its further commitment to the international community’s efforts to
complete polio eradication. UNICEF, the organization that procures the vaccine to meet
global needs, announced it will purchase significant quantities of Inactivated Polio
Vaccine (IPV) from Sanofi Pasteur and make it available based on country needs and
vaccination plans. To achieve the goal of polio eradication by 2018, the World Health
Organization (WHO) recommends that by end 2015, all children receive routinely at least
one dose of IPV in over 120 countries that solely use Oral Polio Vaccine.

To view the Multimedia News Release, please click:


In order to support rapid and widespread adoption of IPV, Sanofi Pasteur – the world’s
largest producer of IPV – and the Bill & Melinda Gates Foundation have developed a joint
price support mechanism, including a financial contribution from both organizations. This
mechanism allows Sanofi Pasteur to offer IPV at a price of EUR0.75 per dose (approximately
US$1) to 73 of the world’s poorest countries. The GAVI Alliance, a global immunisation
partnership, will make IPV available for inclusion in routine immunisation schedules in
these countries.

This announcement underscores Sanofi Pasteur’s commitment to offer unparalleled
volumes of high-quality IPV across a broad range of countries and economic situations at
differential prices in an unprecedented, global rollout.




SOURCE Sanofi Pasteur

Source: PR Newswire

comments powered by Disqus